Evidence map›Paper›PMID 40936615›Full record

ReviewChemical science2025

Predicting reaction conditions: a data-driven perspective.

Matthew Ball, Dragos Horvath, Thierry Kogej, Mikhail Kabeshov, Alexandre Varnek

Abstract readReview
In one paragraph

Review in Chemical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Matthew BallMolecular AI, Discovery Sciences RD, AstraZeneca 431 83 Gothenburg Sweden.ORCID https://orcid.org/0009-0008-8777-1778
Dragos HorvathLaboratory of Cheminformatics, University of Strasbourg 67081 Strasbourg France varnek@unistra.fr.
Thierry KogejMolecular AI, Discovery Sciences RD, AstraZeneca 431 83 Gothenburg Sweden.
Mikhail KabeshovMolecular AI, Discovery Sciences RD, AstraZeneca 431 83 Gothenburg Sweden.ORCID https://orcid.org/0009-0009-2290-6130
Alexandre VarnekLaboratory of Cheminformatics, University of Strasbourg 67081 Strasbourg France varnek@unistra.fr.ORCID https://orcid.org/0000-0003-1886-925X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The selection of optimal reaction conditions is a critical challenge in synthetic chemistry, influencing the efficiency, sustainability, and scalability of chemical processes. While machine learning (ML) has emerged as a promising tool for predicting reaction conditions in computer-aided synthesis planning (CASP), existing approaches face many significant challenges, including data quality, sparsity, choice of reaction representation and method evaluation. Recent studies have suggested that these models may fail to surpass literature-derived popularity baselines, underscoring these problems. In this work, we provide a critical review of state-of-the-art ML techniques, identifying innovations which have addressed the key challenges facing researchers when modelling conditions. To illustrate how relevant reaction representations can improve existing models, we perform a case study of heteroaromatic Suzuki-Miyaura reactions, derived from US patent data (USPTO). Using Condensed Graph of Reaction-based inputs, we demonstrate how this alternative representation can enhance the predictive power of a model beyond popularity baselines. Finally, we propose future directions for the field beyond improving data quality, suggesting potential options to mitigate data issues prevalent in existing literature data. This perspective aims to guide researchers in understanding and overcoming current limitations in computational reaction condition prediction.

Identifiers

PMID40936615
PMCPMC12422413

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.